BIOTALYS NV (BTLS.BR) Fundamental Analysis & Valuation

EBR:BTLS • BE0974386188

Current stock price

2.33 EUR
+0.1 (+4.48%)
Last:

This BTLS.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. BTLS.BR Profitability Analysis

1.1 Basic Checks

  • In the past year BTLS has reported negative net income.
  • In the past year BTLS has reported a negative cash flow from operations.
  • In the past 5 years BTLS always reported negative net income.
  • BTLS had a negative operating cash flow in each of the past 5 years.
BTLS.BR Yearly Net Income VS EBIT VS OCF VS FCFBTLS.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M

1.2 Ratios

  • The Return On Assets of BTLS (-51.18%) is worse than 92.86% of its industry peers.
  • BTLS has a Return On Equity of -74.88%. This is amonst the worse of the industry: BTLS underperforms 88.57% of its industry peers.
Industry RankSector Rank
ROA -51.18%
ROE -74.88%
ROIC N/A
ROA(3y)-45.95%
ROA(5y)-38.32%
ROE(3y)-62.54%
ROE(5y)-51.65%
ROIC(3y)N/A
ROIC(5y)N/A
BTLS.BR Yearly ROA, ROE, ROICBTLS.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

  • BTLS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BTLS.BR Yearly Profit, Operating, Gross MarginsBTLS.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. BTLS.BR Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, BTLS has more shares outstanding
  • BTLS has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, BTLS has an improved debt to assets ratio.
BTLS.BR Yearly Shares OutstandingBTLS.BR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M
BTLS.BR Yearly Total Debt VS Total AssetsBTLS.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • An Altman-Z score of 3.86 indicates that BTLS is not in any danger for bankruptcy at the moment.
  • With a decent Altman-Z score value of 3.86, BTLS is doing good in the industry, outperforming 80.00% of the companies in the same industry.
  • A Debt/Equity ratio of 0.16 indicates that BTLS is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.16, BTLS is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z 3.86
ROIC/WACCN/A
WACCN/A
BTLS.BR Yearly LT Debt VS Equity VS FCFBTLS.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

  • BTLS has a Current Ratio of 3.61. This indicates that BTLS is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 3.61, BTLS belongs to the best of the industry, outperforming 94.29% of the companies in the same industry.
  • BTLS has a Quick Ratio of 3.61. This indicates that BTLS is financially healthy and has no problem in meeting its short term obligations.
  • BTLS's Quick ratio of 3.61 is amongst the best of the industry. BTLS outperforms 95.71% of its industry peers.
Industry RankSector Rank
Current Ratio 3.61
Quick Ratio 3.61
BTLS.BR Yearly Current Assets VS Current LiabilitesBTLS.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. BTLS.BR Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 19.48% over the past year.
EPS 1Y (TTM)19.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7.58%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 9.09% on average over the next years. This is quite good.
  • BTLS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.35% yearly.
EPS Next Y-0.88%
EPS Next 2Y12.39%
EPS Next 3Y9.09%
EPS Next 5YN/A
Revenue Next Year-52%
Revenue Next 2Y14.02%
Revenue Next 3Y19.35%
Revenue Next 5YN/A

3.3 Evolution

BTLS.BR Yearly Revenue VS EstimatesBTLS.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2023 2024 2025 2026 2027 2M 4M 6M 8M
BTLS.BR Yearly EPS VS EstimatesBTLS.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -0.1 -0.2 -0.3 -0.4

More info and screens

Find the best growth stocksShow best growing peers

0

4. BTLS.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for BTLS. In the last year negative earnings were reported.
  • Also next year BTLS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BTLS.BR Price Earnings VS Forward Price EarningsBTLS.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BTLS.BR Per share dataBTLS.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.39%
EPS Next 3Y9.09%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BTLS.BR Dividend Analysis

5.1 Amount

  • No dividends for BTLS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BTLS.BR Fundamentals: All Metrics, Ratios and Statistics

BIOTALYS NV

EBR:BTLS (4/24/2026, 7:00:00 PM)

2.33

+0.1 (+4.48%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)03-27
Earnings (Next)N/A
Inst Owners21.37%
Inst Owner ChangeN/A
Ins Owners4.83%
Ins Owner ChangeN/A
Market Cap87.54M
Revenue(TTM)N/A
Net Income(TTM)-14.83M
Analysts84.44
Price Target6.12 (162.66%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-15.09%
PT rev (3m)-23.73%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.68%
EPS NY rev (3m)-2.68%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.42
P/tB 4.54
EV/EBITDA N/A
EPS(TTM)-0.41
EYN/A
EPS(NY)-0.29
Fwd EYN/A
FCF(TTM)-0.33
FCFYN/A
OCF(TTM)-0.33
OCFYN/A
SpS0
BVpS0.53
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -51.18%
ROE -74.88%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-45.95%
ROA(5y)-38.32%
ROE(3y)-62.54%
ROE(5y)-51.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5.8%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.61
Quick Ratio 3.61
Altman-Z 3.86
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)25.97%
Cap/Depr(5y)109.26%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7.58%
EPS Next Y-0.88%
EPS Next 2Y12.39%
EPS Next 3Y9.09%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-52%
Revenue Next 2Y14.02%
Revenue Next 3Y19.35%
Revenue Next 5YN/A
EBIT growth 1Y9.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-5.38%
EBIT Next 3Y7.46%
EBIT Next 5YN/A
FCF growth 1Y37.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y35.88%
OCF growth 3YN/A
OCF growth 5YN/A

BIOTALYS NV / BTLS.BR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BIOTALYS NV (BTLS.BR) stock?

ChartMill assigns a fundamental rating of 2 / 10 to BTLS.BR.


What is the valuation status of BIOTALYS NV (BTLS.BR) stock?

ChartMill assigns a valuation rating of 0 / 10 to BIOTALYS NV (BTLS.BR). This can be considered as Overvalued.


What is the profitability of BTLS stock?

BIOTALYS NV (BTLS.BR) has a profitability rating of 0 / 10.


What is the financial health of BIOTALYS NV (BTLS.BR) stock?

The financial health rating of BIOTALYS NV (BTLS.BR) is 6 / 10.


What is the earnings growth outlook for BIOTALYS NV?

The Earnings per Share (EPS) of BIOTALYS NV (BTLS.BR) is expected to decline by -0.88% in the next year.